Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02387099
Title Dose EScalation Induction of EvERolimus (Desiree)
Acronym Desiree
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors German Breast Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.